Диссертация (1139759), страница 22
Текст из файла (страница 22)
De Jong [et al] // HPB. – 2010. – V. 12 (8). –P. 509–522.130. Suh C.H. The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis offocal nodular hyperplasia: a systematic review and meta-analysis / C.H. Suh, K.W.Kim, G.Y. Kim [et al] // Eur. Radiol. – 2015. – V. 25 (4). – P. 950-960.131. Suh Y.J. Differentiation of hepatic hyperintense lesions seen on gadoxeticacid-enhanced hepatobiliary phase MRI / Y.J.
Suh, M.J. Kim, J.Y. Choi [et al] //Am. J. Roentgenol. – 2011. – V. 197 (1). – P. 44-52.132. Sutherland T. Solid focal liver lesion characterisation with apparentdiffusion coefficient ratios / T. Sutherland, E. Steele, F. van Tonder [et al] // J.Med. Imaging Radiat. Oncol. – 2014. – V.58(1). – P.32-37.133. Takayasu K. Clinical implication of hypovascular hepatocellular carcinomastudied in 4,474 patients with solitary tumour equal or less than 3 cm / K.Takayasu, S.
Arii, M. Sakamoto [et al] // Liver Int. – 2013. – V. 33 (5). – P. 762770.134. Tamada T. T2-Weighted Magnetic Resonance Imaging of the Liver:Evaluation of the Effect in Signal Intensity After Gd-EOB-DTPAEnhancement / T.Tamada, K. Ito, K. Yoshida [et al] // J Comput Assist Tomogr. – 2010. – V. 34(2).– P.
182-186.135. Taouli B. Diffusion-weighted MR imaging of the liver / B. Taouli, D.M.Koh // Radiology. – 2010. – V. 254(1). – P.47-66.136. Taouli B. Evaluation of liver diffusion isotropy and characterization of focalhepatic lesions with two single-shot echo-planar MR imaging sequences:138prospective study in 66 patients / B. Taouli, V. Vilgrain, E. Dumont [et al] //Radiology. – 2003. – V. 226(1). – P. 71-78.137.
Testa M.L. Is DWI/ADC a useful tool in the characterization of focal hepaticlesions suspected of malignancy? / M.L. Testa, R. Chojniak, L.S. Sene [et al] //PLoS One. – 2014. – V. 9(7): e101944.138. Thomsen H.S. T1 hyperintensity in the brain after multiple intravenousinjections of gadolinium-based contrast agents / H.S. Thomsen // Acta Radiol. –2016. – V. 57(4). – P. 389-391.139. Tsurusaki M. Comparison of gadoxetic acid-enhanced magnetic resonanceimaging and contrast-enhanced computed tomography with histopathologicalexaminations for the identification of hepatocellular carcinoma: a multicenterphase III study / M. Tsurusaki, K. Sofue, H.
Isoda [et al] // J. Gastroenterol. –2016. – V. 51 (1). – P. 71-79.140. van Aalten S.M. Hepatocellular adenomas: correlation of MR imagingfindings with pathologic subtype classification / S.M. van Aalten, M.G. Thomeer,T. Terkivatan [et al] // Radiology. – 2011. – V. 261 (1). – P. 172-181.141. van Beers B.E. Primovist, Eovist: what to expect? / B.E. Van Beers, C.M.Pastor, H.K. Hussain // J. Hepatol. – 2012.
– V.57(2). – P. 421-429.142. van Kessel C. S. et al. MR liver imaging with Gd-EOB-DTPA: a delay timeof 10 minutes is sufficient for lesion characterisation / C. S. van Kessel, W. B.Veldhuis, M. A. A. J. van den Bosch [et al] // Eur. Radiol. – 2012. – V. 22(10). –P. 2153–2160.143. van Kessel C.S. Focal nodular hyperplasia: hepatobiliary enhancementpatterns on gadoxetic-acid contrast-enhanced MRI / C.S. van Kessel, E. de Boer,F.J. ten Kate [et al] // Abdom Imaging. – 2013. – V. 38 (3). – P.
490-501.144. Vander Borght S. Diagnostic and pathogenetic implications of theexpression of hepatic transporters in focal lesions occurring in normal liver / S.Vander Borght, L. Libbrecht, H. Blokzijl [et al] // J. Pathol. – 2005. – V. 207 (4). –P. 471-482.139145. Vijay A. Hepatocellular adenoma: An update / A.Vijay, A. Elaffandi, H.Khalaf // Wld J. Hepatol.
– 2015. – V. 7(25). – P. 2603–2609.146. Vyas M. A practical diagnostic approach to hepatic masses / M. Vyas, D. Jain[et al] // Indian J Pathol Microbiol. – 2018. –V. 61(1). – P. 2-17.147. Vogl T.J. Liver tumors: comparison of MR imaging with Gd-EOB-DTPAand Gd-DTPA / T.J Vogl, S. Kümmel, R. Hammerstingl [et al] // Radiology. –1996.
– V.200(1). – P. 59-67.148. Wáng Y.X. A comprehensive literatures update of clinical researches ofsuperparamagnetic resonance iron oxide nanoparticles for magnetic resonanceimaging / Y.X. Wáng, J.M. Idée // Quant. Imaging Med. Surg. – 2017. – V.7(1). –P. 88-122.149.
Wang Y.X. Superparamagnetic iron oxide based MRI contrast agents:Current status of clinical application / Y.X. Wang // Quant. Imaging Med. Surg. –2011. – V. 1(1). – P. 35-40.150. Watanabe A. Magnetic resonance imaging of the cirrhotic liver: An update /A. Watanabe, M. Ramalho, M. AlObaidy [et al] // World J. Hepatol.
– 2015. – V. 7(3). – P. 468-487.151. Weinmann H.J. A new lipophilic gadolinium chelate as a tissue-specificcontrast medium for MRI / H.J. Weinmann, G. Schuhmann-Giampieri, H. SchmittWillich [et al] // Magn. Reson. Med. – 1991. – V.22 (2). – P. 233-237.152. World Cancer Report 2014 / edited by Bernard W. Stewart and Christopher P.Wild. – Lyon, 2014. – 632 p.153. Wu J.W. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPAenhanced magnetic resonance imaging for identification of hepatocellularcarcinoma in patients with cirrhosis of different degrees of severity / J.W.
Wu,Y.C. Yu, X.L. Qu [et al] // World J Gastroenterol. – 2018. – V.24(3). – P.415-423.154.Wu W. Pattern of distant extrahepatic metastases in primary liver cancer: aSEER based study / W. Wu, X. He, D. Andayani [et al] // J Cancer. – 2017. – V.8(12). – P. 2312-2318.140155. Xu P.J. Added value of breathhold diffusion-weighted MRI in detection ofsmall hepatocellular carcinoma lesions compared with dynamic contrast-enhancedMRI alone using receiver operating characteristic curve analysis / P.J.
Xu, F.H.Yan, J.H. Wang [et al] // J. Magn. Reson. Imaging. – 2009. – V. 29(2). – P.341349.156. Yoneda N. Benign Hepatocellular Nodules: Hepatobiliary Phase ofGadoxetic Acid-enhanced MR Imaging Based on Molecular Background / N.Yoneda, O. Matsui, A. Kitao [et al] // Radiographics. – 2016. – V. 36 (7). – P.2010-2027.157. Yoshikawa M.I. Relation between cancer cellularity and apparent diffusioncoefficient values using diffusion-weighted magnetic resonance imaging in breastcancer / M.I. Yoshikawa, S. Ohsumi, S. Sugata [et al] // Radiat Med.
– 2008. – V.26(4). – P.222-226.158. Zech C.J. Diagnostic performance and description of morphological featuresof focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonanceimaging: results of a multicenter trial / C.J. Zech, L. Grazioli, J. Breuer [et al] //Invest. Radiol. – 2008. – V.43. – P.504–511.159. Zech C.J. Health-economic evaluation of three imaging strategies in patientswith suspected colorectal liver metastases: Gd-EOB-DTPA-enhanced MRI vs.extracellular contrast media-enhanced MRI and 3-phase MDCT in Germany, Italyand Sweden / C.J.
Zech, L. Grazioli, E. Jonas [et al] // Eur. Radiol. – 2009. – V. 19(3). – P.753-763.160. Zelhof B. Correlation of diffusion-weighted magnetic resonance data withcellularity in prostate cancer / B. Zelhof, M. Pickles, G. Liney [et al] // BJU Int. –2009. – V. 103(7). – P. 883-888..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
